Meeting Banner
Abstract #2043

NAD+/NADH dysregulation and brain homeostasis in the gclm-KO mouse: towards biomarker identification for schizophrenia.

Radek Skupienski1,2, Kim Quang Do1, and Lijing Xin2
1Center for psychiatric neurosciences, Lausanne University Hospital (CHUV), Prilly-Lausanne, Switzerland, 2Center for Biomedical Imaging (CIBM), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Nicotinamide adenine dinucleotide is a key player of cell metabolism. Previously we demonstrated the feasibility of in vivo NAD measurement, by 31P-MRS, in mouse brain. Actually we established the profile of cerebral NAD+, NADH and NAD+/NADH in a mouse model relevant for schizophrenia and we followed the metabolites regulation during the development by a combination of 1H-31P-MRS. We highlighted redox dysregulation associated with glutathione deficit, from 20 to 250 days old animals. This study provides prospective for understanding the molecular mechanism affecting brain development and regulation together with identification of potential therapeutic biomarker relevant for the pathophysiology of schizophrenia.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords